Change in medial frontal cerebral metabolite concentrations following bariatric surgery.
BMI
HbA1c
bariatric surgery
brain health
diabetes
magnetic resonance spectroscopy
obesity
Journal
NMR in biomedicine
ISSN: 1099-1492
Titre abrégé: NMR Biomed
Pays: England
ID NLM: 8915233
Informations de publication
Date de publication:
07 2023
07 2023
Historique:
revised:
13
12
2022
received:
10
09
2022
accepted:
29
12
2022
medline:
15
6
2023
pubmed:
12
1
2023
entrez:
11
1
2023
Statut:
ppublish
Résumé
Obesity is associated with adverse effects on brain health, including an increased risk of neurodegenerative diseases. Changes in cerebral metabolism may underlie or precede structural and functional brain changes. While bariatric surgery is known to be effective in inducing weight loss and improving obesity-related medical comorbidities, few studies have examined whether it may be able to improve brain metabolism. In the present study, we examined changes in cerebral metabolite concentrations in participants with obesity who underwent bariatric surgery. Thirty-five patients with obesity (body mass index ≥ 35 kg/m
Substances chimiques
Creatine
MU72812GK0
Choline
N91BDP6H0X
Inositol
4L6452S749
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e4897Subventions
Organisme : NIAAA NIH HHS
ID : T32 AA025877
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK099334
Pays : United States
Informations de copyright
© 2023 John Wiley & Sons Ltd.
Références
Hruby A, Hu FB. The epidemiology of obesity: A big picture. Pharmacoeconomics. 2015;33(7):673-689. doi:10.1007/s40273-014-0243-x
GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13-27. doi:10.1056/NEJMoa1614362
Collaboration TERF. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet. 2011;377(9771):1085-1095. doi:10.1016/S0140-6736(11)60105-0
Jiang L, Rong J, Wang Y, et al. The relationship between body mass index and hip osteoarthritis: A systematic review and meta-analysis. Joint Bone Spine. 2011;78(2):150-155. doi:10.1016/j.jbspin.2010.04.011
Jiang L, Tian W, Wang Y, et al. Body mass index and susceptibility to knee osteoarthritis: A systematic review and meta-analysis. Joint Bone Spine. 2012;79(3):291-297. doi:10.1016/j.jbspin.2011.05.015
Lauby-Secretan B, Scoccianti C, Loomis D, et al. Body fatness and cancer-Viewpoint of the IARC Working Group. N Engl J Med. 2016;375(8):794-798. doi:10.1056/NEJMsr1606602
Singh GM, Danaei G, Farzadfar F, et al. The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: A pooled analysis. PLoS ONE. 2013;8(7):e65174. doi:10.1371/journal.pone.0065174
Wyatt SB, Winters KP, Dubbert PM. Overweight and obesity: Prevalence, consequences, and causes of a growing public health problem. Am J Med Sci. 2006;331(4):166-174. doi:10.1097/00000441-200604000-00002
Sui SX, Pasco JA. Obesity and brain function: The brain-body crosstalk. Medicina (Kaunas). 2020;56(10):499. doi:10.3390/medicina56100499
Dekkers IA, Jansen PR, Lamb HJ. Obesity, brain volume, and white matter microstructure at MRI: A cross-sectional UK Biobank study. Radiology. 2019;291(3):763-771. doi:10.1148/radiol.2019181012
García-García I, Michaud A, Dadar M, et al. Neuroanatomical differences in obesity: meta-analytic findings and their validation in an independent dataset. Int J Obes (Lond). 2019;43(5):943-951. doi:10.1038/s41366-018-0164-4
Kharabian Masouleh S, Arélin K, Horstmann A, et al. Higher body mass index in older adults is associated with lower gray matter volume: implications for memory performance. Neurobiol Aging. 2016;40:1-10. doi:10.1016/j.neurobiolaging.2015.12.020
Medic N, Ziauddeen H, Ersche KD, et al. Increased body mass index is associated with specific regional alterations in brain structure. Int J Obes (Lond). 2016;40(7):1177-1182. doi:10.1038/ijo.2016.42
Jefferson AL, Massaro JM, Wolf PA, et al. Inflammatory biomarkers are associated with total brain volume: The Framingham Heart Study. Neurology. 2007;68(13):1032-1038. doi:10.1212/01.wnl.0000257815.20548.df
Isozumi K. Obesity as a risk factor for cerebrovascular disease. Keio J Med. 2004;53(1):7-11. doi:10.2302/kjm.53.7
Kim KW, Seo H, Kwak MS, Kim D. Visceral obesity is associated with white matter hyperintensity and lacunar infarct. Int J Obes (Lond). 2017;41(5):683-688. doi:10.1038/ijo.2017.13
Yatsuya H, Yamagishi K, North KE, Brancati FL, Stevens J, Folsom AR. Associations of obesity measures with subtypes of ischemic stroke in the ARIC study. J Epidemiol. 2010;20(5):347-354. doi:10.2188/jea.JE20090186
Mazon JN, de Mello AH, Ferreira GK, Rezin GT. The impact of obesity on neurodegenerative diseases. Life Sci. 2017;182:22-28. doi:10.1016/j.lfs.2017.06.002
Elias MF, Elias PK, Sullivan LM, Wolf PA, D'Agostino RB. Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes Relat Metab Disord. 2003;27(2):260-268. doi:10.1038/sj.ijo.802225
Beydoun MA, Beydoun HA, Wang Y. Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis. Obes Rev. 2008;9(3):204-218. doi:10.1111/j.1467-789X.2008.00473.x
Gazdzinski S, Kornak J, Weiner MW, Meyerhoff DJ. Body mass index and magnetic resonance markers of brain integrity in adults. Ann Neurol. 2008;63(5):652-657. doi:10.1002/ana.21377
Haley AP, Gonzales MM, Tarumi T, Miles SC, Goudarzi K, Tanaka H. Elevated cerebral glutamate and myo-inositol levels in cognitively normal middle-aged adults with metabolic syndrome. Metab Brain Dis. 2010;25(4):397-405. doi:10.1007/s11011-010-9221-y
Williamson JB, Lamb DG, Porges EC, et al. Cerebral metabolite concentrations are associated with cortical and subcortical volumes and cognition in older adults. Front Aging Neurosci. 2021;12:479. doi:10.3389/fnagi.2020.587104
Tran T, Ross B, Lin A. Magnetic resonance spectroscopy in neurological diagnosis. Neurol Clin. 2009;27(1):21-60. doi:10.1016/j.ncl.2008.09.007
Gazdzinski S, Millin R, Kaiser LG, et al. BMI and neuronal integrity in healthy, cognitively normal elderly: a proton magnetic resonance spectroscopy study. Obesity (Silver Spring). 2010;18(4):743-748. doi:10.1038/oby.2009.325
Coplan JD, Fathy HM, Abdallah CG, et al. Reduced hippocampal N-acetyl-aspartate (NAA) as a biomarker for overweight. NeuroImage: Clin. 2014;4:326-335. doi:10.1016/j.nicl.2013.12.014
Daniele G, Campi B, Saba A, et al. Plasma N-Acetylaspartate is related to age, obesity, and glucose metabolism: Effects of antidiabetic treatment and bariatric surgery. Front Endocrinol. 2020;11:216. doi:10.3389/fendo.2020.00216
Baslow MH. N-acetylaspartate in the vertebrate brain: metabolism and function. Neurochem Res. 2003;28(6):941-953. doi:10.1023/a:1023250721185
Pilande E, So S, Lim U, et al. Proton magnetic resonance spectroscopy (1H-MRS)-based neurometabolite levels and cognitive function in relation to visceral obesity and non-alcoholic fatty liver disease (P14-019-19). Curr Dev Nutr. 2019;3(Supplement_1):nzz052-P14. doi:10.1093/cdn/nzz052.P14-019-19
Gonzales MM, Takashi T, Eagan DE, Tanaka H, Vaghasia M, Haley AP. Indirect effects of elevated body mass index on memory performance through altered cerebral metabolite concentrations. Psychosom Med. 2012;74(7):691-698. doi:10.1097/PSY.0b013e31825ff1de
Geissler A, Fründ R, Schölmerich J, Feuerbach S, Zietz B. Alterations of cerebral metabolism in patients with diabetes mellitus studied by proton magnetic resonance spectroscopy. Exp Clin Endocrinol Diabetes. 2003;111(7):421-427. doi:10.1055/s-2003-44289
Sinha S, Ekka M, Sharma U, Pandey RM, Jagannathan NR. Assessment of changes in brain metabolites in Indian patients with type-2 diabetes mellitus using proton magnetic resonance spectroscopy. BMC Res Notes. 2014;7:41. doi:10.1186/1756-0500-7-41
Lin Y, Zhou J, Sha L, et al. Metabolite differences in the lenticular nucleus in type 2 diabetes mellitus shown by proton MR spectroscopy. Am J Neuroradiol. 2013;34(9):1692-1696. doi:10.3174/ajnr.A3492
Ajilore O, Haroon E, Kumaran S, et al. Measurement of brain metabolites in patients with type 2 diabetes and major depression using proton magnetic resonance spectroscopy. Neuropsychopharmacology. 2007;32(6):1224-1231. doi:10.1038/sj.npp.1301248
Heikkilä O, Lundbom N, Timonen M, Groop PH, Heikkinen S, Mäkimattila S. Hyperglycaemia is associated with changes in the regional concentrations of glucose and myo-inositol within the brain. Diabetologia. 2009;52(3):534-540. doi:10.1007/s00125-008-1242-2
Sahin I, Alkan A, Keskin L, et al. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus. J Diabetes Complications. 2008;22(4):254-260. doi:10.1016/j.jdiacomp.2007.03.007
Mäkimattila S, Malmberg-Cèder K, Häkkinen AM, et al. Brain metabolic alterations in patients with type 1 diabetes-hyperglycemia-induced injury. J Cereb Blood Flow Metab. 2004;24(12):1393-1399. doi:10.1097/01.WCB.0000143700.15489.B2
Lizarbe B, Cherix A, Duarte JMN, Cardinaux JR, Gruetter R. High-fat diet consumption alters energy metabolism in the mouse hypothalamus. Int J Obes (Lond). 2019;43(6):1295-1304. doi:10.1038/s41366-018-0224-9
Lizarbe B, Soares AF, Larsson S, Duarte JMN. Neurochemical modifications in the hippocampus, cortex and hypothalamus of mice exposed to long-term high-fat diet. Front Neurosci. 2018;12:985. doi:10.3389/fnins.2018.00985
Lim SI, Song KH, Yoo CH, Woo DC, Choe BY. High-fat diet-induced hyperglutamatergic activation of the hippocampus in mice: A proton magnetic resonance spectroscopy study at 9.4T. Neurochem Int. 2018;114:10-17. doi:10.1016/j.neuint.2017.12.007
Ribeiro M, Castelhano J, Petrella LI, et al. High-fat diet induces a neurometabolic state characterized by changes in glutamate and N-acetylaspartate pools associated with early glucose intolerance: An in vivo multimodal MRI study. J Magn Reson Imaging. 2018;48(3):757-766. doi:10.1002/jmri.25942
Chelala L, O'Connor EE, Barker PB, Zeffiro TA. Meta-analysis of brain metabolite differences in HIV infection. NeuroImage: Clin. 2020;28:102436. doi:10.1016/j.nicl.2020.102436
Wang H, Tan L, Wang HF, et al. Magnetic resonance spectroscopy in Alzheimer's disease: systematic review and meta-analysis. J Alzheimers Dis. 2015;46:1049-1070. doi:10.3233/JAD-143225
Henigsberg N, Kalember P, Hrabač P, et al. 1-H MRS changes in dorsolateral prefrontal cortex after donepezil treatment in patients with mild to moderate Alzheimer's disease. Coll Antropol. 2011;35(1):159-162.
Moon CM, Kim BC, Jeong GW. Effects of donepezil on brain morphometric and metabolic changes in patients with Alzheimer's disease: A DARTEL-based VBM and 1H-MRS. Magn Reson Imaging. 2016;34(7):1008-1016. doi:10.1016/j.mri.2016.04.025
Young AC, Yiannoutsos CT, Hegde M, et al. Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection. Neurology. 2014;83(18):1592-1600. doi:10.1212/WNL.0000000000000932
Sailasuta N, Ross W, Ananworanich J, et al. Change in brain magnetic resonance spectroscopy after treatment during acute HIV infection. PLoS ONE. 2012;7(11):e49272. doi:10.1371/journal.pone.0049272
Auer MK, Sack M, Lenz JN, et al. Effects of a high-caloric diet and physical exercise on brain metabolite levels: a combined proton MRS and histologic study. J Cereb Blood Flow Metab. 2015;35(4):554-564. doi:10.1038/jcbfm.2014.231
Nagothu RS, Reddy YI, Rajagopalan A, Varma R. Right dorsolateral frontal lobe N-Acetyl aspartate and myoinositol concentration estimation in type 2 diabetes with magnetic resonance spectroscopy. J Clin Diagn Res. 2015;9(7):CC16-CC19. doi:10.7860/JCDR/2015/14153.6234
Garcia-Serrano AM, Mohr AA, Philippe J, Skoug C, Spégel P, Duarte JMN. Cognitive impairment and metabolite profile alterations in the hippocampus and cortex of male and female mice exposed to a fat and sugar-rich diet are normalized by diet reversal. Aging Dis. 2022;13(1):267-283. doi:10.14336/AD.2021.0720
Colquitt JL, Picot J, Loveman E, Clegg AJ. Surgery for obesity. Cochrane Database Syst Rev. 2009;2. doi:10.1002/14651858.CD003641.pub3
Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f5934. doi:10.1136/bmj.f5934
Arterburn DE, Courcoulas AP. Bariatric surgery for obesity and metabolic conditions in adults. BMJ. 2014;349:g3961. doi:10.1136/bmj.g3961
Maciejewski ML, Arterburn DE, Van Scoyoc L, et al. Bariatric surgery and long-term durability of weight loss. JAMA Surg. 2016;151(11):1046-1055. doi:10.1001/jamasurg.2016.2317
Gazdzinski SP, Gaździńska AP, Orzeł J, et al. Intragastric balloon therapy leads to normalization of brain magnetic resonance spectroscopic markers of diabetes in morbidly obese patients. NMR Biomed. 2018;31(9):e3957. doi:10.1002/nbm.3957
García-García I, Michaud A, Jurado MÁ, Dagher A, Morys F. Mechanisms linking obesity and its metabolic comorbidities with cerebral grey and white matter changes. Rev Endocr Metab Disord. 2022;23(4):833-843. doi:10.1007/s11154-021-09706-5
Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444(7121):840-846. doi:10.1038/nature05482
Chumakova-Orin M, Vanetta C, Moris DP, Guerron AD. Diabetes remission after bariatric surgery. World J Diabetes. 2021;12(7):1093-1101. doi:10.4239/wjd.v12.i7.1093
Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med. 1993;30(6):672-679. doi:10.1002/mrm.1910300604
Oeltzschner G, Zöllner HJ, Hui SCN, et al. Osprey: Open-source processing, reconstruction & estimation of magnetic resonance spectroscopy data. J Neurosci Methods. 2020;343:108827. doi:10.1016/j.jneumeth.2020.108827
Zhu H, Barker PB. MR spectroscopy and spectroscopic imaging of the brain. J Magn Reson Neuroimag. 2011;711:203-226. doi:10.1007/978-1-61737-992-5_9
Li BSY, Wang H, Gonen O. Metabolite ratios to assumed stable creatine level may confound the quantification of proton brain MR spectroscopy. Magn Reson Imaging. 2003;21(8):923-928. doi:10.1016/S0730-725X(03)00181-4
Gasparovic C, Song T, Devier D, et al. Use of tissue water as a concentration reference for proton spectroscopic imaging. Magn Reson Med. 2006;55(6):1219-1226. doi:10.1002/mrm.20901
Mair P, Wilcox R. Robust statistical methods in R using the WRS2 package. Behav Res Methods. 2020;52(2):464-488. doi:10.3758/s13428-019-01246-w
Zahr NM, Mayer D, Rohlfing T, Sullivan EV, Pfefferbaum A. Imaging neuroinflammation? A perspective from MR spectroscopy. Brain Pathol. 2014;24(6):654-664. doi:10.1111/bpa.12197
Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011;29(1):415-445. doi:10.1146/annurev-immunol-031210-101322
Spencer S. Perinatal nutrition programs neuroimmune function long-term: mechanisms and implications. Front Neurosci. 2013;7:144. doi:10.3389/fnins.2013.00144
Shu CJ, Benoist C, Mathis D. The immune system's involvement in obesity-driven type 2 diabetes. Semin Immunol. 2012;24(6):436-442. doi:10.1016/j.smim.2012.12.001
De Souza CT, Araujo EP, Bordin S, et al. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology. 2005;146(10):4192-4199. doi:10.1210/en.2004-1520
Miller AA, Spencer SJ. Obesity and neuroinflammation: A pathway to cognitive impairment. Brain Behav Immun. 2014;42:10-21. doi:10.1016/j.bbi.2014.04.001
Milanski M, Degasperi G, Coope A, et al. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J Neurosci. 2009;29(2):359-370. doi:10.1523/JNEUROSCI.2760-08.2009
Nguyen JCD, Killcross AS, Jenkins TA. Obesity and cognitive decline: role of inflammation and vascular changes. Front Neurosci. 2014;8:375. doi:10.3389/fnins.2014.00375
Brand A, Richter-Landsberg C, Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci. 1993;15(3-5):289-298. doi:10.1159/000111347
Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci. 1993;13(3):981-989. doi:10.1523/JNEUROSCI.13-03-00981.1993
Chang L, Munsaka SM, Kraft-Terry S, Ernst T. Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain. J Neuroimmune Pharmacol. 2013;8(3):576-593. doi:10.1007/s11481-013-9460-x
Kantarci K, Knopman DS, Dickson DW, et al. Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements. Radiology. 2008;248(1):210-220. doi:10.1148/radiol.2481071590
Fernando KTM, McLean MA, Chard DT, et al. Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. Brain. 2004;127(6):1361-1369. doi:10.1093/brain/awh153
Reinke S, Broadhurst D, Sykes B, et al. Metabolomic profiling in multiple sclerosis: insights into biomarkers and pathogenesis. Mult Scler. 2014;20(10):1396-1400. doi:10.1177/1352458513516528
Murray ME, Przybelski SA, Lesnick TG, et al. Early Alzheimer's disease neuropathology detected by proton MR spectroscopy. J Neurosci. 2014;34(49):16247-16255. doi:10.1523/JNEUROSCI.2027-14.2014
Tracey IDP, Carr CA, Guimaraes AR, Worth JL, Navia BA, Gonzalez RG. Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex: a proton magnetic resonance spectroscopic study. Neurology. 1996;46(3):783-788. doi:10.1212/WNL.46.3.783
Maul S, Giegling I, Rujescu D. Proton magnetic resonance spectroscopy in common dementias-current status and perspectives. Front Psych. 2020;11:769.
Chen J, Haase N, Haange SB, et al. Roux-en-Y gastric bypass contributes to weight loss-independent improvement in hypothalamic inflammation and leptin sensitivity through gut-microglia-neuron-crosstalk. Mol Metab. 2021;48:101214. doi:10.1016/j.molmet.2021.101214
McGavigan AK, Henseler ZM, Garibay D, et al. Vertical sleeve gastrectomy reduces blood pressure and hypothalamic endoplasmic reticulum stress in mice. Dis Model Mech. 2017;10(3):235-243. doi:10.1242/dmm.027474
van de Sande-Lee S, Melhorn SJ, Rachid B, et al. Radiologic evidence that hypothalamic gliosis is improved after bariatric surgery in obese women with type 2 diabetes. Int J Obes (Lond). 2020;44(1):178-185. doi:10.1038/s41366-019-0399-8
Guerrero-Hreins E, Foldi CJ, Oldfield BJ, Stefanidis A, Sumithran P, Brown RM. Gut-brain mechanisms underlying changes in disordered eating behaviour after bariatric surgery: a review. Rev Endocr Metab Disord. 2022;23(4):733-751. doi:10.1007/s11154-021-09696-4
Kim JP, Lentz MR, Westmoreland SV, et al. Relationships between astrogliosis and 1H MR spectroscopic measures of brain choline/creatine and myo-inositol/creatine in a primate model. Am J Neuroradiol. 2005;26(4):752-759.
Jung C, Ichesco E, Ratai EM, et al. Magnetic resonance imaging of neuroinflammation in chronic pain: a role for astrogliosis? Pain. 2020;161(7):1555-1564. doi:10.1097/j.pain.0000000000001815